Hypothesis
Version 1
Preserved in Portico This version is not peer-reviewed
On the Consequences of Cell Fusion in COVID-19 Patients
Version 1
: Received: 2 June 2021 / Approved: 4 June 2021 / Online: 4 June 2021 (08:21:00 CEST)
Version 2 : Received: 7 September 2021 / Approved: 9 September 2021 / Online: 9 September 2021 (10:54:14 CEST)
Version 2 : Received: 7 September 2021 / Approved: 9 September 2021 / Online: 9 September 2021 (10:54:14 CEST)
A peer-reviewed article of this Preprint also exists.
Journal reference: Oncotarget 2021
DOI: 10.18632/oncotarget.28088
Abstract
This commentary proposes how the coronavirus SARS- CoV-2 can contribute to clinical manifestations of COVID-19 by producing syncytia.
Keywords
cell fusion; syncytia; hybrids; viruses; coronaviruses; SARS-CoV-2; COVID-19; blood coagulation cascade; thrombosis; cancer
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.
Leave a public commentSend a private comment to the author(s)